CF
COLL icon

Cantor Fitzgerald’s Collegium Pharmaceutical COLL Stock Holding History

Cantor Fitzgerald’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,971
Closed -$335K – 322
2023
Q3 		$335K Buy
14,971
+3,477
+30% +$79.3K 0.01% 379
2023
Q2 		$247K Hold
11,494
– – 0.01% 460
2023
Q1 		$276K Sell
11,494
-321
-3% -$8.51K 0.01% 502
2022
Q4 		$274K Buy
11,815
+84
+0.7% +$1.69K 0.01% 534
2022
Q3 		$188K Sell
11,731
-84
-0.7% -$1.48K ﹤0.01% 604
2022
Q2 		$209K Buy
+11,815
New +$199K ﹤0.01% 654

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cantor Fitzgerald's COLL Position: Q4 2023 in Review

Cantor Fitzgerald sold out of Collegium Pharmaceutical (COLL) in Q4 2023, closing a stake of 14,971 shares — an estimated $335K sold.

Cantor Fitzgerald first reported a position in COLL in Q2 2022 and held it in 6 quarters. The position peaked at $335K in Q3 2023. 193 funds tracked by Wall St. Rank hold COLL as of Q4 2023.

  • Cantor Fitzgerald reported no remaining Collegium Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 14,971 Collegium Pharmaceutical shares in Q4 2023, an estimated $335K.
  • Cantor Fitzgerald first reported a position in Collegium Pharmaceutical in Q2 2022 and held it in 6 quarters.
  • Cantor Fitzgerald's Collegium Pharmaceutical position peaked at $335K in Q3 2023.
  • 193 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2023.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.